Chronic kidney disease (CKD) is defined as structural and functional abnormalities of the kidney present for at least 3 months, with or without decreased glomerular filtration rate (GFR), including abnormalities in the composition of blood or urine. As CKD progresses, metabolic abnormalities may occur, and CVD is the leading cause of death. This may lead to atherosclerotic changes in the arteries supplying the heart, reflected through deranged lipid levels and adversely affecting renal function. In the present case study, a hypertensive patient aged 56 years with a history of myocardial infarction (MI), fatty liver disease (FLD) Grade II, and prostatomegaly had abnormal renal functions with reduced GFR, raised serum creatinine, and deranged total cholesterol (TC) and sr. triglycerides (TGAs), hence being later diagnosed with CKD. The combination of Gokshurak Churna (GC) and Trinpachmula Kwath (TK) is prescribed with Arogyavardhini Vat (AVT). At the end of three months of the treatment with the above intervention, there is a significant reduction in Sr.Cr from 2.08 mg/dl to 0.75 mg/dl, Sr. uric acid from 6.7 mg/dl to 5.3 mg/dl, TC from 233 mg/dl to 193.0 mg/dl, and Sr.TGA’s levels from 166.0 mg/dl to 69.0 mg/dl, which increases the estimated GFR from 37 ml/min/1. The extent of FLD changes from grade II to grade I. During the whole treatment, the patient's B.P. remains under control. The combination of GC and TK with AVT is a good intervention to treat CKD patients with dyslipidemia. This is effective in reducing the progression of disease, restoring the functions of the kidneys, and improving the quality of life of the patient.
Keywords: Arogyavardhini vati(AVT), Chronic Kidney Disease(CKD), Dyslipidemia, Gokshura Churna(GC), Trinpanchmula Ksheerpaka (TK)